CCL20
C-C motif chemokine 20
Also known as: CCL20_HUMAN, CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78556
- Gene
- CCL20
- Ensembl
- ENSG00000115009
- Chromosome
- 2
- Canonical length
- 96 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This antimicrobial gene belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The protein encoded by this gene displays chemotactic activity for lymphocytes and can repress proliferation of myeloid progenitors. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
Canonical amino-acid sequenceUniProt
96 residues, UniProt reviewed canonical sequence.
>P78556|CCL20
1 MCCTKSLLLA ALMSVLLLHL CGESEAASNF DCCLGYTDRI LHPKFIVGFT RQLANEGCDI
61 NAIIFHTKKK LSVCANPKQT WVKYIVRLLS KKVKNMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCL20 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 179 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 179 nTPM
- tonsil: 155 nTPM
- gallbladder: 153 nTPM
- lung: 40 nTPM
- appendix: 30 nTPM
- rectum: 25 nTPM
Single-cell type
- monocytes: 884 nCPM
- endometrial glandular cells: 784 nCPM
- esophageal apical cells: 722 nCPM
- esophageal suprabasal cells: 648 nCPM
- neutrophils: 593 nCPM
- gastric progenitor cells: 473 nCPM
Immune cell
- MAIT T-cell: 2.7 nTPM
- memory CD4 T-cell: 1.1 nTPM
- memory CD8 T-cell: 0.6 nTPM
- T-reg: 0.5 nTPM
- plasmacytoid DC: 0.3 nTPM
- naive CD4 T-cell: 0.2 nTPM
Brain region
- cerebellum: 10 nTPM
- white matter: 9.6 nTPM
- thalamus: 8.4 nTPM
- cerebral cortex: 8.3 nTPM
- basal ganglia: 7.4 nTPM
- pons: 7.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.59
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-mediated signaling
- cell chemotaxis
- cell-cell signaling
- chemotaxis
- defense response to bacterium
- immune response
- inflammatory response
- positive regulation of T cell migration
- signal transduction
- T cell migration
- thymocyte migration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCL20 as an antibody target. Whether an autoantibody or antibody against CCL20 could matter depends on whether native CCL20 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCL20 is annotated as secreted, so native CCL20 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CCL20 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...